“We are very excited to partner with SpiroChem such that our portfolio companies can gain access to highest quality medical chemistry expertise and support! And…
Mariela Salas27.10.2020
“We are extremely pleased with the successful closing of our first fund. This would not have been possible without the trust and support of our…
juliet schaaf24.09.2020
We are very pleased to welcome CSL Behring, one of the largest biotech companies in the world, as a partner in BaseLaunch Phase II. Read the…
Jérémie Meyer30.07.2020
Special Report: The latest addition to the partner portfolio all the way from Asia Pacific. A warm welcome to Bridge Biotherapeutics, for which CEO, James Lee,…
Jérémie Meyer14.07.2020
We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at…
Jérémie Meyer24.06.2020
We are proud to announce that Roche has become a founding partner in the next phase of BaseLaunch. With this commitment, Roche renews its partnership…
Jérémie Meyer15.05.2020
There is an opportunity to participate in a research study interview taking place for those with knowledge of the biopharmaceutical industry in Switzerland. The research should…
Jérémie Meyer11.05.2020
We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing…
Jérémie Meyer11.05.2020
“Go start a biotech company in a strong biotech ecosystem” is our conclusion from this Nature paper, which tracks down every biotech start-up emerging (between…
Jérémie Meyer08.05.2020
